Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges
Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges have?
Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges has 8 citations in the OpenAlex counts ScholarIQ stores.
When was Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges published?
Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges has 2023 year in the ScholarIQ index.
What is the open-access status of Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges?
Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges has closed oa status in the ScholarIQ index.
What is the DOI of Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges?
The DOI for Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges is on the source record.
What is the PMID of Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges?
The PMID for Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges is on the source record.
What is the OpenAlex record for Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges?
The OpenAlex for Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges is on the source record.